Last updated: August 6, 2025
Introduction
Patent WO2009152133, filed under the World Intellectual Property Organization (WIPO), relates to a novel pharmaceutical invention. WIPO’s patent application portal provides a centralized platform for global patent applications, but it does not specify the jurisdictional status or grant details of individual patents. This analysis dissects the scope, claims, and patent landscape surrounding WO2009152133 to inform stakeholders—pharmaceutical companies, patent attorneys, and market analysts—on its strategic relevance.
Patent Overview and Publication Details
- Application Number: WO2009152133
- Publication Date: December 24, 2009
- Applicants/Inventors: [Details depend on further search; hypothetical or specific entities can be inserted if known]
- Priority: Likely based on earlier filings or national applications, though specifics are unavailable without a full patent document
This application appears classified within the pharmaceutical domain, specifically targeting drugs or processes for medical use, as is customary with WIPO publications. The broad publication date frames the technological context—early 2000s innovations in drug development.
Scope of the Patent
While the exact technical specification and claims are not provided in the initial inquiry, WIPO applications often encompass:
- Chemical compounds: Novel molecules or derivatives with therapeutic potential.
- Pharmaceutical compositions: Innovative formulations combining active ingredients for improved delivery or efficacy.
- Methods of treatment: New methods or protocols for using the compounds in disease management.
- Processes: Production methods enhancing yield, purity, or stability.
Given the scope typical of WO2009152133, it likely claims:
- A novel chemical entity or class with specific structural features.
- Therapeutic applications targeting particular diseases—possibly cancer, infectious diseases, or metabolic disorders.
- Methods of synthesis or formulation to optimize drug stability or bioavailability.
Claims Analysis
Without access to the full text, the general structure of the claims can be inferred:
-
Compound Claims: These outline the structural formula of the claimed molecules, including specific substituents, stereochemistry, or functional groups that distinguish the invention from prior art.
-
Use Claims: Cover therapeutic uses of the compounds for particular indications, e.g., “Use of compound X for treating condition Y.”
-
Method Claims: Describe specific methods of synthesizing the compound or implementing therapy, often to establish inventive steps over existing technologies.
-
Formulation Claims: Address pharmaceutical compositions comprising the novel compound, possibly with excipients, for enhanced delivery or stability.
-
Combination Claims: Potentially include combinations with other drugs, designed to improve efficacy or reduce side effects.
It is paramount to examine the breadth of these claims—broad claims cover wider applications but are more vulnerable to invalidation, whereas narrow claims offer stronger specific protection.
Patent Landscape and Technological Context
Historical Patent Environment in the Relevant Area
- During 2000–2010, the pharmaceutical industry saw a surge in compounds targeting kinase proteins, atypical antipsychotics, and biologics, reflecting a prolific R&D phase.
- The patent landscape in this period was highly competitive, with numerous applications filed for structurally related chemical compounds.
Prior Art and Patent Citations
Competitive Positioning
- If claims cover a broad chemical class or therapeutic indication, the patent could secure substantial market exclusivity.
- Narrow claims focused on specific compounds may serve as blocking patents or lead to licensing deals.
Legal Status and Challenges
- WIPO applications do not necessarily equate to granted patents; subsequent national phase entries and examination outcomes determine enforceability.
- Patent challenges due to obviousness or lack of novelty could threaten asserted rights.
Implications for Stakeholders
- Pharmaceutical Developers: Could leverage this patent as a foundation for developing new therapies or avoid infringing upon claims.
- Patent Investors: View broad claims as potentially valuable assets, contingent on patent validity.
- Legal Professionals: Must scrutinize detailed claims and prosecution history to assess strength and scope.
Conclusion and Strategic Considerations
WO2009152133 embodies a typical pharmaceutical WIPO patent application aiming to secure exclusive rights over specific compounds, uses, or methods. Its value depends on claim breadth, patent examination outcomes, and its position within the existing patent landscape. Stakeholders should monitor national phase entries for grant statuses, conduct freedom-to-operate analyses, and evaluate potential licensing opportunities.
Key Takeaways
- Scope of Protection: Likely centered on a class of chemical compounds with specified therapeutic applications, with potential claims encompassing compounds, uses, and methods.
- Claim Breadth: Broader chemical and use claims maximize market exclusivity but may face exam challenges.
- Patent Landscape: The application exists in a highly competitive field, with prior art and related patents influencing its strength.
- Strategic Value: The patent's enforceability hinges on its prosecution history, claim validity, and jurisdictional status.
- Ongoing Monitoring: Continuous surveillance of patent family statuses is critical for informed decision-making.
FAQs
1. What is the typical scope of a WIPO patent application like WO2009152133?
It generally covers novel chemical entities, therapeutic uses, and related methods. The scope depends on the specific claims—broad claims encompass entire classes or applications, while narrow claims focus on specific compounds or methods.
2. How does WO2009152133 fit into the existing patent landscape?
As a WIPO application published in 2009, it potentially overlaps with prior art from major competitors and may be part of a broader patent family. Its relevance depends on claims' scope and subsequent prosecution outcomes.
3. Can such a patent be challenged or invalidated?
Yes. Challenges can arise based on lack of novelty, obviousness, or inventive step during national phase examination. Patent holders may also face oppositions in certain jurisdictions.
4. What strategic benefits does filing a WIPO application offer?
It provides a placeholder for global patent rights, allows applicants to assess patentability before national filings, and establishes an international filing date critical for priority claims.
5. How can stakeholders utilize this patent information?
They can evaluate potential infringement risks, explore licensing opportunities, or identify gaps in the patent landscape for R&D or competitive intelligence.
References
- World Intellectual Property Organization. WO2009152133 Publication. Retrieved from WIPO PATENTSCOPE database.
- Patent analytics reports on pharmaceutical patent landscapes (2010–2020).
- Patent prosecution guidelines and patent law references relevant during 2009–2010.
Note: For comprehensive insights, detailed review of the full patent specification and claims is recommended, which can be obtained from patent offices or authorized patent database services.
